Document Type : Original Article
Authors
Savitri Neuromind Care, Mahavir Nagar, Varanasi, Uttar Pradesh, India
Abstract
BACKGROUND: Substance abuse and mental disorder often coexist and may cause several
consequences in sociooccupational functioning and health care and management. Indian data are
sparse in this area.
OBJECTIVES: The aim of the study was to examine the sociodemographic profile, pattern, and
prevalence of alcohol and substance use among person suffering with mental illness and to compare
with those without mental illness.
METHODS: A total of 80 treatment‑seeking patients with mental illness and 80 nontreatment seeking
healthy accompanying persons were assessed for current substance use. Mental illness was screened
using Structured Clinical Interview for DSM‑IV Axis I Disorders and the diagnosis was made as per
DSM IV, semi‑structured sociodemographic pro forma was also applied. The data collected were
analyzed using the Chi‑square and Student’s t‑test.
RESULTS: Substance use was found 2.5 times higher among cases (56.2%) than controls (22.5%).
Substance‑using participants comprised mainly males belonging to rural residence. The substance
using cases were more unmarried, less educated, poorer economically, and more nuclear family
structures that substance‑using controls. When compared with non‑substance using cases, cases
with substance use had more males than females and lower education. Although both groups were
almost similar in term of marital status, family structure, residence, and socioeconomic status.
Among both groups, most common substance use was tobacco, followed by alcohol and cannabis.
Although all the substances were more prevalent among cases than controls. The prevalence of
any substance use was highest among cases with psychotic disorder (77.3%), followed by unipolar
depression (62.5%), bipolar affective disorder (41.7%), and anxiety disorders (21.4%). Tobacco and
cannabis use was most prevalent among cases suffering with psychotic disorders, whereas alcohol
use was most prevalent among cases suffering with unipolar depression.
CONCLUSIONS: Mentally ill individuals are vulnerable to develop substance use, thus they are doubly
jeopardized. The susceptibility of these individuals stem from lesser insight, need for stimulation, to
decrease the anhedonia induced by psychoactive medicines and poor awareness hence this group
of individuals has several health and social consequences; therefore, they require due attention.
A better care, support, and education are needed for substance using patients with mental illness
to improve their prognosis and also help in their appropriate rehabilitation.
Keywords
contribution of risk factors: Global Burden of Disease Study.
Lancet 1997;349:1436‑42.
2. Ananth J, Vandewater S, Kamal M, Brodsky A, Gamal R, Miller M.
Missed diagnosis of substance abuse in psychiatric patients.
Psychiatr Serv 1989;40:297‑9.
3. Condren RM, O’Connor J, Browne R. Prevalence and patterns of
substance misuse in schizophrenia. Psychiatrist 2001;25:17‑20.
4. Blanchard JJ, Brown SA, Horan WP, Sherwood AR. Substance use
disorders in schizophrenia: Review, integration, and a proposed
model. Clin Psychol Rev 2000;20:207‑34.
5. Barnett JH, Werners U, Secher SM, Hill KE, Brazil R, Masson K,
et al. Substance use in a population‑based clinic sample of people
with first‑episode psychosis. Br J Psychiatry 2007;190:515‑20.
6. Graham HL, Maslin J, Copello A, Birchwood M, Mueser K,
McGovern D, et al. Drug and alcohol problems amongst
individuals with severe mental health problems in an inner city
area of the UK. Soc Psychiatry Psychiatr Epidemiol 2001;36:448‑55.
7. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC,
Compton W, et al. Prevalence and co‑occurrence of substance use
disorders and independent mood and anxiety disorders: Results
from the national epidemiologic survey on alcohol and related
conditions. Arch Gen Psychiatry 2004;61:807‑16.
8. Grant BF, Stinson FS, Hasin DS, Dawson DA, Chou SP, Ruan WJ,
et al. Prevalence, correlates, and comorbidity of bipolar I
disorder and axis I and II disorders: Results from the national
epidemiologic survey on alcohol and related conditions. J Clin
Psychiatry 2005;66:1205‑15.
9. Compton WM, Conway KP, Stinson FS, Grant BF. Changes in
the prevalence of major depression and comorbid substance use
disorders in the United States between 1991‑1992 and 2001‑2002.
Am J Psychiatry 2006;163:2141‑7.
10. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al.
Comorbidity of mental disorders with alcohol and other drug
abuse. Results from the epidemiologic catchment area (ECA)
study. JAMA 1990;264:2511‑8.
11. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M,
Eshleman S, et al. Lifetime and 12‑month prevalence of DSM‑III‑R
psychiatric disorders in the United States. Results from the
National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8‑19.
12. Dubé KC, Handa SK. Drug use in health and mental illness in an
Indian population. Br J Psychiatry 1971;118:345‑6.
13. Saddichha S, Sur S, Sinha BN, Khess CR. How is substance
use linked to psychosis? A study of the course and patterns of
substance dependence in psychosis. Subst Abus 2010;31:58‑67.14. Srivastava A, Sreejayan K, Joseph AM, Sharma PS. Indian research
on comorbidities. Indian J Psychiatry 2010;52:S246‑9.
15. Singh S, Balhara YP. A review of Indian research on co‑occurring
psychiatric disorders and alcohol use disorders. Indian J Psychol
Med 2016;38:10‑9.
16. Pal H, Srivastava A, Dwivedi SN, Pandey A, Nath J. Prevalence
of drug abuse in India through a national household survey. Int
J Curr Sci 2015;15:e103‑13.
17. Ray R. The Extent, Pattern and Trends of drug Abuse in India:
National Survey. Ministry of Social Justice and Empowerment,
Government of India & United Nations Office on Drugs and
Crime, Regional Office for South Asia; 2004.
18. Gururaj G, Varghese M, Benegal V, Rao GN, Pathak K, Singh LK,
et al. National mental health survey of India, 2015–16: Summary.
Bengaluru Natl Inst Ment Health Neuro Sci NIMHANS
publication no. 128.2016:90‑109.
19. Dube KC, Handa SK. Drug habit in health and mental disorders.
Indian J Psychiatry 1969;11:23‑9.
20. Sethi BB, Trivedi JK. Drug abuse in rural populations. Indian J
Psychiatry 1997;21:211-6.
21. Aich TK, Sinha VK, Khess CR, Singh S. Demographic and clinical
correlates of substance abuse comorbidity in schizophrenia.
Indian J Psychiatry 2004;46:135‑9.
22. Chand P, Thirthalli J, Murthy P. Substance use disorders
among treatment naïve first‑episode psychosis patients. Compr
Psychiatry 2014;55:165‑9.
23. Chandra PS, Carey MP, Carey KB, Jairam KR, Girish NS,
Rudresh HP, et al. Prevalence and correlates of tobacco use and
nicotine dependence among psychiatric patients in India. Addict
Behav 2005;30:1290‑9.
24. Gupta A, Gauba D, Bhatia T, Deshpande SN. A study of
tobacco and substance abuse among mentally ill outpatients
in a tertiary care general hospital. J Ment Health Hum Behav
2016;21(2):117‑121
25. Hauli KA, Ndetei DM, Jande MB, Kabangila R. The prevalence
of substance use among psychiatric patients: The case study of
Bugando Medical Centre, Mwanza (Northern Tanzania). Subst
Abus 2011;32:238‑41.
26. Abayomi O, Ojo TM, Ibrahim N, Adelufosi AO, Obasan A.
Prevalence and correlates of substance use among persons with
mental disorders in a Nigerian psychiatric hospital. Afr J Drug
Alcohol Stud 2012;11 (1):29‑35.
27. Bhawna G. Burden of smoked and smokeless tobacco
consumption in India – Results from the global adult tobacco
survey India (GATS‑India)‑2009‑201. Asian Pac J Cancer Prev
2013;14:3323‑9.
28. Kavanagh DJ, Waghorn G, Jenner L, Chant DC, Carr V, Evans M,
et al. Demographic and clinical correlates of comorbid substance
use disorders in psychosis: Multivariate analyses from an
epidemiological sample. Schizophr Res 2004;66:115‑24.
29. Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K.
Drug and alcohol use among patients with schizophrenia and
related psychoses: Levels and consequences. Schizophr Res
2004;67:157‑66.
30. Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP,
Canive JM, et al. Substance use in persons with schizophrenia:
Baseline prevalence and correlates from the NIMH CATIE study.
J Nerv Ment Dis 2006;194:164‑72.
31. Gurillo P, Jauhar S, Murray RM, MacCabe JH. Does tobacco use
cause psychosis? Systematic review and meta‑analysis. Lancet
Psychiatry 2015;2:718‑25.
32. Duke PJ, Pantelis C, Barnes TR. South Westminster schizophrenia
survey. Alcohol use and its relationship to symptoms, tardive
dyskinesia and illness onset. Br J Psychiatry 1994;164:630‑6.
33. Menezes PR, Johnson S, Thornicroft G, Marshall J, Prosser D,
Bebbington P, et al. Drug and alcohol problems among individuals
with severe mental illness in South London. Br J Psychiatry
1996;168:612‑9.
34. Haqqi S. Substance abuse in schizophrenia – A short report.
Procedia Soc Behav Sci 2010;5:2239‑41.
35. Sullivan LE, Fiellin DA, O’Connor PG. The prevalence and impact
of alcohol problems in major depression: A systematic review.
Am J Med 2005;118:330‑41.
36. Kumar PN, Raju SS. Impact of substance abuse comorbidity on
psychopathology and pattern of remission in mania. Indian J
Psychiatry 1998;40:357‑63.
37. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar
disorder. Bipolar Disord 2001;3:181‑8.
38. Chengappa KN, Levine J, Gershon S, Kupfer DJ. Lifetime
prevalence of substance or alcohol abuse and dependence among
subjects with bipolar I and II disorders in a voluntary registry.
Bipolar Disord 2000;2:191‑5.
39. Cerullo MA, Strakowski SM. The prevalence and significance of
substance use disorders in bipolar type I and II disorder. Subst
Abuse Treat Prev Policy 2007;2:29.
40. Bauer MS, Altshuler L, Evans DR, Beresford T, Williford WO,
Hauger R, et al. Prevalence and distinct correlates of anxiety,
substance, and combined comorbidity in a multi‑site public sector
sample with bipolar disorder. J Affect Disord 2005;85:301‑15.
41. Boden JM, Fergusson DM. Alcohol and depression. Addiction
2011;106:906‑14.
42. Minozzi S, Davoli M, Bargagli AM, Amato L, Vecchi S, Perucci CA,
et al. An overview of systematic reviews on cannabis and
psychosis: Discussing apparently conflicting results. Drug Alcohol
Rev 2010;29:304‑17.
43. Radhakrishnan R, Wilkinson ST, D’Souza DC. Gone to pot – A
review of the association between cannabis and psychosis. Front
Psychiatry 2014;5:54.
)